Von Eschenbach Nomination Criticized By Conservatives Over Plan B Switch
This article was originally published in The Tan Sheet
Executive Summary
The nomination of Andrew von Eschenbach to FDA full commissioner is now being challenged by conservatives, in reaction to the agency's reconsideration of Barr Labs' switch application for emergency contraceptive Plan B